{"id":"W2924267060","doi":"10.1080/09546634.2019.1587145","title":"Efficacy and safety of guselkumab, administered with a novel patient-controlled injector (One-Press), for moderate-to-severe psoriasis: results from the phase 3 ORION study","year":2019,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"Janssen Research and Development; Eli Lilly and Company","keywords":"Medicine; Psoriasis; Psoriasis Area and Severity Index; Placebo; Adverse effect; Dosing; Interim analysis; Internal medicine; Randomized controlled trial; Dermatology; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000208329,0.0003329859,0.001237353,0.00007065715,0.0001549365,0.00002891291,0.000202416,0.0001778764,0.0000325434],"category_scores_gemma":[0.0001707249,0.0001547596,0.0002321329,0.00008727632,0.00006040473,0.00008544118,0.00004943508,0.0001166902,0.000008367087],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007393702,"about_ca_system_score_gemma":0.0000868028,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000387881,"about_ca_topic_score_gemma":0.0000224746,"domain_scores_codex":[0.9979007,0.0003663667,0.00100404,0.000339935,0.0001122389,0.0002767505],"domain_scores_gemma":[0.996828,0.001753035,0.000810573,0.0003463227,0.000190461,0.00007166861],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8797246,0.02317146,0.01535874,0.00002317448,0.01446701,0.0001111555,0.008434759,0.0002808423,0.02265977,0.00008799024,0.0003993444,0.03528115],"study_design_scores_gemma":[0.8214074,0.07207971,0.04811683,0.0003492873,0.005178455,0.0007080869,0.003523095,0.00004859434,0.043111,0.00006475473,0.004790442,0.0006223093],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936316,0.00157072,0.0001170047,0.0004290536,0.0002984785,0.002933199,0.0009460147,0.00001450571,0.00005944382],"genre_scores_gemma":[0.9987794,0.0001330397,0.0006946493,0.00006767481,0.00003786736,0.0001106477,0.00007727106,0.00001555795,0.00008395346],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05831717,"threshold_uncertainty_score":0.6310914,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04277174648646291,"score_gpt":0.2797984276950329,"score_spread":0.23702668120857,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}